Health ❯ Medicine ❯ Pharmaceuticals

Weight Loss

GLP-1 Drugs Ozempic Mounjaro GLP-1 Medications Orforglipron Clinical Trials GLP-1 Agonists Semaglutide Oral Medications GLP-1 Receptor Agonists

FDA-Cleared Wegovy Pill Becomes First Oral GLP-1 for Weight Loss

Novo is undercutting rivals on cash pricing to seize early share among self-pay users.

FDA Approves First Wegovy Pill for Chronic Weight Management

FDA Clears Wegovy Weight-Loss Pill, U.S. Launch Set for January

Terry Dubrow Claims GLP-1 Weight Loss Can Produce an 'Ozempic Penis'

Wegovy Sales Soar as UK Mounjaro Price Jumps 170%

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial

New Oral β2 Agonist Preserves Muscle in Early Weight-Loss Trials

Eli Lilly’s Oral GLP-1 Pill Matches Injectables in Weight and Blood Sugar Control

Germany Faces Surge in Forged Prescriptions for Weight Loss Injections

Three Arrested After Unlicensed Weight-Loss Jab Leaves Woman Hospitalized

‘Ozempic Teeth’ Emerges as a Serious Dental Risk for Weight-Loss Drug Users

Three Arrested in Selby Over Illegal Slimming Injections After Woman's Hospitalisation

‘Ozempic Mouth’ Identified as New Cosmetic Concern for Weight-Loss Drug Users

Novo Nordisk Faces Investor Turmoil as Wegovy Sales and Market Share Decline

Amy Schumer Embraces Mounjaro and Hormone Therapy for Improved Health

Rising Use of Ozempic Raises Health, Ethical, and Social Concerns

Amgen's Weight-Loss Drug Shows Promise but Faces Investor Skepticism

James Corden Reveals Ozempic Failed to Address His Food Addiction

Novo Nordisk's Amycretin Pill Shows Promising Weight Loss Results in Early Trial

Eli Lilly's Mounjaro Outperforms Novo Nordisk's Ozempic in Weight Loss Study